Gsk annual operating margin
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Gsk's operating margin was 24.28% for fiscal 2025.
View full Gsk company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 24.28% | +11.47 pp |
| 2024 | 2024-12-31 | 12.82% | −9.42 pp |
| 2023 | 2023-12-31 | 22.24% | +0.30 pp |
| 2022 | 2022-12-31 | 21.94% | +4.30 pp |
| 2021 | 2021-12-31 | 17.64% | −6.91 pp |
| 2020 | 2020-12-31 | 24.55% | +3.93 pp |
| 2019 | 2019-12-31 | 20.62% | +2.83 pp |
| 2018 | 2018-12-31 | 17.79% | +4.25 pp |
| 2017 | 2017-12-31 | 13.54% | +4.22 pp |
| 2016 | 2016-12-31 | 9.32% | −33.83 pp |
| 2015 | 2015-12-31 | 43.15% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|
Over the last five reported fiscal years, Gsk's operating margin decreased from 24.55% to 24.28%, a change of −0.27 percentage points.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Gsk filings at SEC.gov ↗